Patent · US Active

RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies

US9885057B2 · kind B2 · utility

20Cited by

23References

20Claims

0Family size

Assignee

University of Massachusetts · US

Inventors

Terence Flotte · Holden, US
Christian Mueller · Wiesbaden, DE
Phillip D. Zamore · Marlborough, US

Key dates

Filing date	Nov 25, 2015
Grant date	Feb 6, 2018
Priority date	—
Expiry date	Nov 25, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.